{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T07:15:54Z","timestamp":1791357354466,"version":"4.3.1"},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"2","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Indian J Psychiatry"],"published-print":{"date-parts":[[2011]]},"DOI":"10.4103\/0019-5545.82537","type":"journal-article","created":{"date-parts":[[2011,6,30]],"date-time":"2011-06-30T07:20:30Z","timestamp":1309418430000},"page":"128","source":"Crossref","is-referenced-by-count":41,"title":["Drug-emergent metabolic syndrome in patients with schizophrenia receiving atypical (second-generation) antipsychotics"],"prefix":"10.4103","volume":"53","author":[{"given":"ParthSingh","family":"Meena","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiv","family":"Gautam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"key-10.4103\/0019-5545.82537-1","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/S0920-9964(99)00191-7","article-title":"Mortality and causes of death in schizophrenia in Stockholm county, Sweden","author":"Osby","year":"2000","journal-title":"Schizophr Res"},{"key":"key-10.4103\/0019-5545.82537-2","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1016\/j.ahj.2005.02.007","article-title":"Schizophrenia and increased risks of cardiovascular disease","author":"Hennekens","year":"2005","journal-title":"Am Heart J"},{"key":"key-10.4103\/0019-5545.82537-3","doi-asserted-by":"crossref","unstructured":"Allebeck P. Schizophrenia: A life shortening disease. Schizophr Bull 1989;15:81-9","DOI":"10.1093\/schbul\/15.1.81"},{"key":"key-10.4103\/0019-5545.82537-4","doi-asserted-by":"crossref","unstructured":"Black DW, Fisher R. Mortality in DSM-III-R schizophrenia. Schizophr Res 1992;7:109-16","DOI":"10.1016\/0920-9964(92)90040-C"},{"key":"key-10.4103\/0019-5545.82537-5","first-page":"S67","article-title":"Medical comorbidity in schizophrenia","author":"Lambert","year":"2003","journal-title":"Med J Aust"},{"key":"key-10.4103\/0019-5545.82537-6","first-page":"15s","article-title":"Metabolic issues and cardiovascular diseases in patients with psychiatric disorders","author":"Casey","year":"2005","journal-title":"Am J Med"},{"key":"key-10.4103\/0019-5545.82537-7","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1001\/jama.288.21.2709","article-title":"The metabolic syndrome and total and cardiovascular disease mortality in middle-aged men","author":"Lakka","year":"2002","journal-title":"JAMA"},{"key":"key-10.4103\/0019-5545.82537-8","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1161\/01.CIR.100.2.123","article-title":"Insulin-resistance syndrome predicts coronary heart disease events in elderly nondiabetic men","author":"Lempi\u00e4inen","year":"1999","journal-title":"Circulation"},{"key":"key-10.4103\/0019-5545.82537-9","doi-asserted-by":"crossref","first-page":"86","DOI":"10.2337\/diacare.22.1.86","article-title":"Hyperinsulinemia cluster predicts the development of Type 2 diabetes independent of a family history of diabetes","author":"Kek\u00e4l\u00e4inen","year":"1999","journal-title":"Diabetes Care"},{"key":"key-10.4103\/0019-5545.82537-10","doi-asserted-by":"crossref","first-page":"683","DOI":"10.2337\/diacare.24.4.683","article-title":"Cardiovascular morbidity and mortality associated with the metabolic syndrome","author":"Isomaa","year":"2001","journal-title":"Diabetes Care"},{"key":"key-10.4103\/0019-5545.82537-11","doi-asserted-by":"crossref","unstructured":"Trevisan M, Liu J, Bahsas FB, Menotti A (Risk Factor and Life Expectancy Research Group): Syndrome X and mortality: A population-based study. Am J Epidemiol 1998;148:958-66.","DOI":"10.1093\/oxfordjournals.aje.a009572"},{"key":"key-10.4103\/0019-5545.82537-12","first-page":"84","article-title":"Metabolic syndrome and cardiovascular disease","author":"Citrome","year":"2004","journal-title":"J psychopharma"},{"key":"key-10.4103\/0019-5545.82537-13","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1093\/oxfordjournals.epirev.a017978","article-title":"Development of the multiple metabolic syndrome: An epidemiologic perspective","author":"Liese","year":"1998","journal-title":"Epidemiol Rev"},{"key":"key-10.4103\/0019-5545.82537-14","unstructured":"Lieberman JA 3 rd , Metabolic changes associated with antipsychotic use. Prim Care Companion J Clin Psychiatry 2004;6:8-13."},{"key":"key-10.4103\/0019-5545.82537-15","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1017\/S0033291798008186","article-title":"The unhealthy lifestyle of people with schizophrenia","author":"Brown","year":"1999","journal-title":"Psychol Med"},{"key":"key-10.4103\/0019-5545.82537-16","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1176\/appi.ajp.160.2.284","article-title":"Impaired fasting glucose tolerance in first-episode, drug-naive patients with schizophrenia","author":"Ryan","year":"2003","journal-title":"Am J Psychiatry"},{"key":"key-10.4103\/0019-5545.82537-17","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1176\/ps.50.6.827","article-title":"Health and self-care practices of persons with schizophrenia","author":"Holmberg","year":"1999","journal-title":"Psychiatr Serv"},{"key":"key-10.4103\/0019-5545.82537-18","doi-asserted-by":"crossref","first-page":"596","DOI":"10.2337\/diacare.27.2.596","article-title":"Consensus development conference on antipsychotic drugs and obesity and diabetes","author":"American","year":"2004","journal-title":"Diabetes Care"},{"key":"key-10.4103\/0019-5545.82537-19","doi-asserted-by":"crossref","first-page":"S397","DOI":"10.1016\/S0924-977X(01)00109-2","article-title":"Extrapyramidal side effects are unacceptable","author":"Kane","year":"2001","journal-title":"Eur Neuropsychopharmacol"},{"key":"key-10.4103\/0019-5545.82537-20","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1176\/appi.ajp.161.3.414","article-title":"Lower risk for tardive dyskinesia associated with second-generation antipsychotics: A systematic review of 1-year studies","author":"Correll","year":"2004","journal-title":"Am J Psychiatry"},{"key":"key-10.4103\/0019-5545.82537-21","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0920-9964(98)00105-4","article-title":"Efficacy and extrapyramidal side-effects of the new antipsychotics olanzapine, quetiapine, risperidone, and sertindole compared to conventional antipsychotics and placebo.A meta-analysis of randomized controlled trials","author":"Leucht","year":"1999","journal-title":"Schizophr Res"},{"key":"key-10.4103\/0019-5545.82537-22","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/S0006-3223(01)01256-2","article-title":"Broad therapeutic uses of atypical antipsychotic medications","author":"Buckley","year":"2001","journal-title":"Biol Psychiatry"},{"key":"key-10.4103\/0019-5545.82537-23","doi-asserted-by":"crossref","unstructured":"Allison DB, Mentore JL, Heo M, Chandler LP, Cappelleri JC, Infante MC, et al. Antipsychotic-induced weight gain: A comprehensive research synthesis. Am J Psychiatry 1999;156:1686-96.","DOI":"10.1176\/ajp.156.11.1686"},{"key":"key-10.4103\/0019-5545.82537-24","doi-asserted-by":"crossref","first-page":"706","DOI":"10.4088\/JCP.v60n1014","article-title":"Relative weight gain among antipsychotics","author":"Masand","year":"1999","journal-title":"J Clin Psychiatry"},{"key":"key-10.4103\/0019-5545.82537-25","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2165\/00002018-200124010-00005","article-title":"Bodyweight gain with atypical antipsychotics: A comparative review","author":"Wetterling","year":"2001","journal-title":"Drug Saf"},{"key":"key-10.4103\/0019-5545.82537-26","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1001\/archpsyc.59.4.337","article-title":"Abnormalities in glucose regulation during antipsychotic treatment of schizophrenia","author":"Newcomer","year":"2002","journal-title":"Arch Gen Psychiatry"},{"key":"key-10.4103\/0019-5545.82537-27","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.4088\/JCP.v68n1113","article-title":"A 12-week randomized clinical trial to evaluate metabolic changes in drug-naive, first-episode psychosis patients treated with haloperidol, olanzapine, or risperidone","author":"Perez-Iglesias","year":"2007","journal-title":"J Clin Psychiatry"},{"key":"key-10.4103\/0019-5545.82537-28","first-page":"1793","article-title":"Effect of olanzapine, risperidone, and haloperidol treatment on weight and body mass index in first episode schizophrenia patients in India: A randomized, double-blind, controlled, prospective study","author":"Saddichha","year":"2007","journal-title":"J Clin Psychiatry"},{"key":"key-10.4103\/0019-5545.82537-29","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1056\/NEJMoa051688","article-title":"Effectiveness of antipsychotic drugs in patients with chronic schizophrenia","author":"Lieberman","year":"2005","journal-title":"N Engl J Med"},{"key":"key-10.4103\/0019-5545.82537-30","first-page":"817","article-title":"Differential effect of clozapine on weight: A controlled study","author":"Bustillo","year":"1996","journal-title":"Am J Psychiatry"},{"key":"key-10.4103\/0019-5545.82537-31","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1176\/appi.ajp.160.2.290","article-title":"changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics","author":"Lindenmayer","year":"2003","journal-title":"Am J Psychiatry"}],"container-title":["Indian Journal of Psychiatry"],"original-title":[],"language":"en","deposited":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T14:55:47Z","timestamp":1786632947000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ovid.com\/10.4103\/0019-5545.82537"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011]]},"references-count":31,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2011]]}},"alternative-id":["82537"],"URL":"https:\/\/doi.org\/10.4103\/0019-5545.82537","relation":{},"ISSN":["0019-5545"],"issn-type":[{"value":"0019-5545","type":"print"}],"subject":[],"published":{"date-parts":[[2011]]}}}